Clinical trials

The purpose of this study is to determine the PK, safety and tolerability of multiple doses of intravenous (i.v.) secukinumab in pediatric participants with JPsA

Investigator

Melissa E Elder

Ages

2 Years - 17 Years

Sexes

All

This study is an open-label, randomized, multicenter trial that incorporates a multi-arm design comparing each of 3 non-TNFi (Tumor Necrosis Factor inhibitor) medications to a second TNFi (active control) within a sequential multiple assignment…

Investigator

Melissa E Elder

Ages

2 Years - 17 Years

Sexes

All